EUVIMEDEUVIMED entdecken
Crossref

Posterior vitreous attachment as a risk factor for endophthalmitis following intravitreal antivascular endothelial growth factor injection

Eyyup Karahan, Durgul Acan, Mine Koru Toprak

International Ophthalmology · 2024

DOI: 10.1007/s10792-024-03101-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Eyyup Karahan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Balikesir University School of Medicine, Balıkesir, Turkey. Hauptthemen laut MEDLINE: Endophthalmitis, Intravitreal Injections, Vascular Endothelial Growth Factor A, Vitrectomy. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the importance of the status of posterior vitreous in eyes with endophthalmitis following intravitreal anti-vascular endothelial growth factor (anti-VEGF). METHODS: The absence or existence of posterior vitreous detachment (PVD) was elicited in 23 eyes of 23 patients with injection related endophthalmitis, during pars plana vitrectomy (PPV) and compared with 24 control eyes of 24 patients who received intravitreal anti-VEGF without any complication. RESULTS: Thirtten (54.2%) out of 24 patients in the control group had full PVD, whereas only 2 (9.5%) out of 23 eyes in endophthalmitis group (p < 0.001) had full PVD. In all eyes without PVD, posterior vitreous was inducted to be detached at least from optic nerve and macular area without any iatrogenic tear. CONCLUSION: The absence of PVD is a factor that increases the risk of endophthalmitis after intravitreal injections. Uncomplicated separation of the posterior vitreous from the retina in PPV contributes to better prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndophthalmitisIntravitreal InjectionsVascular Endothelial Growth Factor AVitrectomyVitreous DetachmentAgedAged, 80 and overFemaleHumansMaleMiddle AgedAngiogenesis InhibitorsBevacizumabRanibizumabRisk FactorsVitreous Body

Stichwörter der Autor:innen

Endophthaimitis vitrectomy studyEndophthalmitisPars plana vitrectomyPosterior vitreous detachment

Substanzen

Angiogenesis InhibitorsBevacizumabRanibizumabVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology, Balikesir University School of Medicine, Balıkesir, Turkey.
  • Department of Ophthalmology, Balikesir University School of Medicine, Balıkesir, Turkey. durgul2029@hotmail.com.

Zitieren

APA

Karahan, E., Acan, D., & Toprak, M. K. (2024). Posterior vitreous attachment as a risk factor for endophthalmitis following intravitreal antivascular endothelial growth factor injection. International Ophthalmology. https://doi.org/10.1007/s10792-024-03101-0

Vancouver

Karahan E, Acan D, Toprak MK. Posterior vitreous attachment as a risk factor for endophthalmitis following intravitreal antivascular endothelial growth factor injection. International Ophthalmology. 2024. doi:10.1007/s10792-024-03101-0

BibTeX
@article{Karahan2024,
  author = {Karahan, Eyyup and Acan, Durgul and Toprak, Mine Koru},
  title = {Posterior vitreous attachment as a risk factor for endophthalmitis following intravitreal antivascular endothelial growth factor injection},
  journal = {International Ophthalmology},
  year = {2024},
  doi = {10.1007/s10792-024-03101-0}
}
Kostenlos starten →